IP Library Granted Patent US 8,916,236
Granted Patent B2
US 8,916,236 · App. 12/527,440 · Granted Dec 23, 2014

Method of forming a (rutile) titanium dioxide-coated platelet-like pigment

Inventor: Patrice Bujard (Courtepin, CH)
Assignee: Ciba Corporation
C09C1/0021C01G23/053C01G23/0536C09C1/0024C09C1/36C01P2002/72C01P2004/20C01P2004/84C01P2006/12C01P2006/60C09C2200/1004C09C2200/102C09C2200/50C09C2220/106
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,916,236
App. No.
12/527,440
Granted
Dec 23, 2014
Kind
B2
Abstract

The invention relates to a method of forming (rutile) titanium dioxide-coated platelet-like pigments in which hydrous titanium dioxide is deposited on platelet-like particles followed by calcining, comprising (a) effecting the titanium deposit in the presence of an α-hydroxy carboxylic acid, especially glycolic acid, or oxalic acid, and an amino acid, especially glycine, alanine, valine, aspartic acid (α-, β- and γ-form); or an amino acid; to the pigments obtained by the method and the use thereof. The method can work in the absence of exogenous metal and Ti(III). The rutile TiO 2 -coated substrate of the present invention has at least the same advantages and characteristics of a tin containing product which includes luster, color, color homogeneity and few small particle formation during manufacture.

Claims (10)

1. A method of forming a rutile titanium dioxide-coated platelet-like pigment in which hydrous titanium dioxide is deposited on platelet-like particles, comprising

(a) effecting the titanium deposit in the presence of an a-hydroxy carboxylic acid and an amino acid selected from the group consisting of alanine, phenylalanine, glycine, proline, cysteine, histidine, glutamine, leucine, isoleucine, arginine, lysine, serine, threonine, tryptophan, methionine, valine, tyrosine and asparagine,

wherein the platelet-like particles have two flat and parallel surfaces with an aspect ratio length to thickness of from about 2:1 to about 1000:1 and a length to width ratio of from 3:1 to 1:1.

2. The method according to claim 1 , comprising, in sequence,

(a) contacting the platelet-like particles with a titanium salt and an a-hydroxy carboxylic acid and an amino acid containing coating bath at a low pH and coating the platelet-like particles with titanium dioxide in the hydrous form at acid pH by deposition from the titanium salt containing coating bath at a low pH.

3. The method according to claim 2 , wherein the pH in step (a) is from 1.2to 2.5.

4. The method according to claim 3 , comprising in addition

(b) removing the titanium dioxide coated particles from the coating bath and washing said particles to remove excess acid and impurities therefrom; and

(c) calcining said particles at a temperature of from 500 to 1000° C. to produce a translucent coating of titanium dioxide in the rutile crystalline form thereon.

5. A method of forming a rutile titanium dioxide-coated platelet-like pigment according to claim 1 wherein the a-hydroxy carboxylic acid is selected from the group consisting of glycolic acid and oxalic acid, and the amino acid is selected from the group consisting of glycine, alanine, and valine.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2023
From: BASF CORPORATION
To: BASF SE
Reel/Frame 064215/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2023
From: BASF SE
To: SUN CHEMICAL B.V.
Reel/Frame 064216/0019 →
MERGER Recorded May 5, 2023
From: BASF PERFORMANCE PRODUCTS LLC
To: BASF CORPORATION
Reel/Frame 063555/0543 →
CHANGE OF NAME Recorded May 5, 2023
From: CIBA CORPORATION
To: BASF PERFORMANCE PRODUCTS LLC
Reel/Frame 063557/0854 →
CONDITIONAL ASSIGNMENT Recorded Sep 16, 2009
From: BUJARD, PATRICE
To: CIBA CORPORATION
Reel/Frame 023240/0453 →
Priority Claims (2)
EP 07103135 · Feb 27, 2007 · regional
EP 07104054 · Mar 13, 2007 · regional
Continuity (1)
Related Publication 20100075031A1 · Mar 25, 2010